Clinical Trials
60 trialsBMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
Northwestern University
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Cancer Research UK
A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1
Cancer Research UK
EBNK-ST-001
Essen Biotech
Oncolytic Virus in Esophageal Squamous Cell Carcinoma
Sichuan University
A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma
West China Hospital
Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.
Fujian Medical University Union Hospital
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
Cancer Research UK
BRIGHT
University Medical Center Groningen
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
NuCana plc
HTL0039732 in Participants With Advanced Solid Tumours
Cancer Research UK
ABIMMUNE
Gustave Roussy, Cancer Campus, Grand Paris
IL15-TransDC
University Hospital, Antwerp
WaKING: Wnt and checKpoint INhibition in Gastric Cancer
Royal Marsden NHS Foundation Trust
PD-L1-PET
Shandong Cancer Hospital and Institute
Chemoradiotherapy in Unresectable Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
BAH250
Essen Biotech
BT1718 in Patients with Advanced Solid Tumours.
Cancer Research UK
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer
Ludwig Institute for Cancer Research
OSAGE
Centre Hospitalier Universitaire de Besancon
SOX-based CRT for Esophageal Cancer.
Zhejiang Provincial People's Hospital
Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)
Oslo University Hospital
Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma
Beijing Friendship Hospital
APROC
Peter MacCallum Cancer Centre, Australia
Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer
SCRI Development Innovations, LLC
Trimodality Management of T1b Esophageal Cancers
M.D. Anderson Cancer Center
TRAP
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Trial of Panitumumab/Cisplatin/Fluorouracil Combined With Radiation in Esophageal Cancer
University of Wisconsin, Madison
REPEAT
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
PembroMab
Western Regional Medical Center
Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer
Fuda Cancer Hospital, Guangzhou
FLOTOR
Oxford University Hospitals NHS Trust
CAR T and PD-1 Knockout Engineered T Cells for Esophageal Cancer
The First Affiliated Hospital of Guangdong Pharmaceutical University
Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer
City of Hope Medical Center
ACTION
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital
CARTEPC
First Affiliated Hospital of Chengdu Medical College
Study of D-Methadone in Patients With Chronic Pain
Memorial Sloan Kettering Cancer Center
Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery
Federation Francophone de Cancerologie Digestive
cd40
Weill Medical College of Cornell University
DC Vaccine Combined With CIK Cells in Patients With Esophagus Cancer
Affiliated Hospital to Academy of Military Medical Sciences
Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates
AHS Cancer Control Alberta
Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer
Roswell Park Cancer Institute
POXX
Duke University
Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction
Johannes Gutenberg University Mainz
Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer
Technical University of Munich
Chemotherapy in Treating Patients With Solid Tumors
Memorial Sloan Kettering Cancer Center
Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer
Fudan University
Multiple Respiration-Correlated Cone Beam Computed Tomography (CT) Scans to Reduce Target Positioning Errors in Radiotherapy Treatment of Thoracic Cancer
Memorial Sloan Kettering Cancer Center